FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

35594211000001100: Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Jul 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107571101000001113 Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107571201000001118 Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has manufactured dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Is a Fluticasone 125micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Is a Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler false Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Is a Combisal true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Is a Fluticasone 125micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free false Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has active ingredient Salmeterol true Inferred relationship Existential restriction modifier
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Has active ingredient Fluticasone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) 120 dose Has AMP True Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start